Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Advaxis Inc (ADXS)  
$0.06 0.00 (0.00%) as of 4:30 Fri 6/3


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 66,230,000
Market Cap: 4.11(M)
Last Volume: 362,100 Avg Vol: 361,089
52 Week Range: $0.062 - $0.062
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Advaxis is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Listeria monocytogenes (Lm) Technology antigen delivery products based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins. Co.'s pipeline of product candidates include: ADXS-503, which is for the cancer indication of non-small cell lung cancer in combination with KEYTRUDA® (pembrolizumab); ADXS-504, which is for the cancer indication of early stage prostate cancer; and ADXS-PSA, which is for the cancer indication of metastatic prostate cancer in combination with KEYTRUDA® (pembrolizumab).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,317,716 1,317,716
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 465
  Page 5 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   O'connor Daniel Chief Executive Officer   •       •      –    2016-12-30 4 A $7.16 $5,671 D/D 792 295,814     -
   Mayes Gregory T. Director   –       •      –    2016-12-30 4 D $7.16 $852 D/D (119) 103,841     -
   Mayes Gregory T. Director   –       •      –    2016-12-30 4 A $7.16 $3,279 D/D 458 103,960     -
   Mckearn Thomas J Director   –       •      –    2016-12-20 4 S $8.08 $99,513 D/D (12,316) 69,804     -
   Bonstein Sara Chief Financial Officer   •       –      –    2016-11-30 4 D $8.31 $457 D/D (55) 81,963     -
   Bonstein Sara Chief Financial Officer   •       –      –    2016-11-30 4 A $8.31 $2,036 D/D 245 82,018     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-11-30 4 D $8.31 $407 D/D (49) 120,969     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-11-30 4 A $8.31 $2,277 D/D 274 121,018     -
   Mayes Gregory T. Chief Business Officer   •       •      –    2016-11-30 4 D $8.31 $482 D/D (58) 103,502     -
   Mayes Gregory T. Chief Business Officer   •       •      –    2016-11-30 4 A $8.31 $2,186 D/D 263 103,560     -
   O'connor Daniel Chief Executive Officer   •       •      –    2016-11-30 4 D $8.31 $740 D/D (89) 295,022     -
   O'connor Daniel Chief Executive Officer   •       •      –    2016-11-30 4 A $8.31 $3,781 D/D 455 295,111     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-11-02 4 S $8.32 $23,271 D/D (2,797) 120,744     -
   O'connor Daniel Chief Executive Officer   •       •      –    2016-11-02 4 S $8.32 $68,557 D/D (8,240) 294,656     -
   Mayes Gregory T. Chief Business Officer   •       •      –    2016-10-31 4 D $8.09 $485 D/D (60) 103,297     -
   Mayes Gregory T. Chief Business Officer   •       •      –    2016-10-31 4 A $8.09 $2,184 D/D 270 103,357     -
   Bonstein Sara Chief Financial Officer   •       –      –    2016-10-31 4 D $8.09 $453 D/D (56) 81,773     -
   Bonstein Sara Chief Financial Officer   •       –      –    2016-10-31 4 A $8.09 $2,039 D/D 252 81,829     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-10-31 4 D $8.09 $955 D/D (118) 123,541     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-10-31 4 A $8.09 $2,273 D/D 281 123,659     -
   O'connor Daniel Chief Executive Officer   •       •      –    2016-10-31 4 D $8.09 $1,869 D/D (231) 302,896     -
   O'connor Daniel Chief Executive Officer   •       •      –    2016-10-31 4 A $8.09 $3,778 D/D 467 303,127     -
   Mayes Gregory T. Chief Business Officer   •       •      –    2016-10-25 4 S $8.23 $157,703 D/D (19,162) 103,087     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-09-30 4 D $10.69 $342 D/D (32) 123,378     -
   Petit Robert Chief Scientific Officer   •       –      –    2016-09-30 4 A $10.69 $2,277 D/D 213 123,410     -
  465 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us